Tuesday, November 13, 2007
Today's Wall Street Journal has a very, very informative article about kidney organ shortages and the possibility of a regulated market to relieve the shortage. See here. As someone long in favor of a regulated market -- or, at least, in favor of giving the market a test -- I'm thrilled by the hint in the article that opposition to market trials seems to be waning. Be sure to read the sidebar exchange between Julio Elias (for) and Al Roth (against).